Abbvie Inc (NYSE:ABBV)
138.14 Delayed Data As of Jun 09 | ![]() Today’s Change | 131.10 Today|||52-Week Range 168.11 | -14.52% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
Previous close | 137.64 |
Today’s open | 137.78 |
Day’s range | 137.07 - 139.19 |
Volume | 4,359,676 |
Average volume (3 months) | 5,942,024 |
Market cap | $241.5B |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
Earnings growth (last year) | +2.68% |
Earnings growth (this year) | -20.07% |
Earnings growth (next 5 years) | -0.50% |
Revenue growth (last year) | +3.30% |
P/E ratio | 32.5 |
Price/Sales | 4.95 |
Price/Book | 14.03 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
AZNAstraZeneca | -0.19 | -0.26% |
PFEPfizer | -0.12 | -0.31% |
NVONovo Nordisk | -1.38 | -0.87% |
NVSNovartis | +0.28 | +0.28% |
Data as of 4:00pm ET, 06/09/2023
Financials
Next reporting date | July 28, 2023 |
EPS forecast (this quarter) | $2.92 |
Annual revenue (last year) | $58.1B |
Annual profit (last year) | $11.8B |
Net profit margin | 20.29% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
